Twist Bioscience
PulseAugur coverage of Twist Bioscience — every cluster mentioning Twist Bioscience across labs, papers, and developer communities, ranked by signal.
4 day(s) with sentiment data
-
AI in Drug Discovery: Algorithms vs. Full Pipeline Value
Two recent AI-driven pharmaceutical developments, one from Anthropic and another from Moderna, have generated significant public interest. Anthropic utilized its Claude model to autonomously design protein binders for 1…
-
Anthropic's Claude AI designs 14/15 disease-targeting proteins autonomously
Anthropic's Claude language models, specifically Mythos Preview and Opus 4.8, have autonomously designed proteins capable of binding to 14 out of 15 targeted diseases. These AI-generated proteins were synthesized and te…
-
Anthropic's Claude AI designs 14 protein binders, outperforming industry norms
Anthropic's Claude AI has successfully designed protein binders for 14 out of 15 targets, with two independent labs synthesizing and testing these designs. The AI achieved hit rates of 26.7% and 22.6%, significantly hig…
-
Anthropic's Claude autonomously designs proteins, exceeding industry benchmarks · 4 sources tracked
Anthropic's Claude models have demonstrated a significant capability in autonomous protein design, a crucial step in drug discovery. Research indicates that Claude, using its tools and internet access with a single expe…
-
Anthropic's Claude AI designs protein binders with high success rate · 6 sources tracked
Anthropic has released a technical report detailing how its Claude model was used to design novel protein binders, a crucial step in drug development. The AI model successfully designed binders for 14 out of 15 targets,…
-
AI Leaders Urge Congress to Mandate DNA Order Screening to Prevent Bioweapons
Leading AI executives and biosecurity experts have jointly signed an open letter to Congress, advocating for mandatory screening of all synthetic DNA and RNA orders. They express concern that increasingly sophisticated …
-
AI CEOs urge Congress to regulate synthetic DNA sales amid bioweapon fears
CEOs from leading AI companies, including OpenAI, Anthropic, and Microsoft, have jointly urged Congress to implement stricter regulations on the sale of synthetic DNA and RNA. They warn that advancements in AI are lower…
-
AI Leaders Urge Congress to Regulate Synthetic DNA Sales
Leading figures in the AI industry, including executives from OpenAI, Anthropic, Microsoft, Meta, and Google DeepMind, have jointly penned an open letter to US lawmakers. They are urging Congress to implement mandatory …